The current state of molecular testing in the treatment of patients with solid tumors, 2019

Author:

El‐Deiry Wafik S.1,Goldberg Richard M.2,Lenz Heinz‐Josef3,Shields Anthony F.4,Gibney Geoffrey T.5,Tan Antoinette R.6,Brown Jubilee7,Eisenberg Burton89,Heath Elisabeth I.10,Phuphanich Surasak11,Kim Edward12,Brenner Andrew J.13,Marshall John L.14ORCID

Affiliation:

1. Associate Dean for Oncologic Sciences, Warren Alpert Medical School; Director, Joint Program in Cancer Biology, Brown University and the Lifespan Cancer Institute; Professor of Pathology & Laboratory Medicine and Professor of Medical ScienceBrown University Providence RI

2. Professor of Medicine and DirectorWest Virginia University Cancer Institute Morgantown WV

3. Professor of Medicine, Norris Comprehensive Cancer CenterUniversity of Southern California Los Angeles CA

4. Professor of OncologyKarmanos Cancer Institute Detroit MI

5. Associate Professor of Medicine, Co‐Leader of the Melanoma Disease GroupLombardi Comprehensive Cancer Institute, MedStar Georgetown Cancer Institute Washington DC

6. Co‐Director of Phase I Program, Department of Solid Tumor Oncology and Investigational TherapeuticsLevine Cancer Institute, Atrium Health Charlotte NC

7. Professor and Associate Director of Gynecologic OncologyLevine Cancer Institute, Atrium Health Charlotte NC

8. Professor of Clinical SurgeryUniversity of Southern California Los Angeles CA

9. Executive Medical DirectorHoag Family Cancer Institute Newport Beach CA

10. Professor of Oncology and MedicineKarmanos Cancer Institute Detroit MI

11. Professor of Neurology, Director, Division of Neuro‐OncologyBarrow Neurological Institute Phoenix AZ

12. Chair, Solid Tumor Oncology and Investigational TherapeuticsLevine Cancer Institute, Atrium Health Charlotte NC

13. Associate Professor of Medicine Mays Cancer Center at University of Texas Health San Antonio Cancer Center San Antonio TX

14. Professor of Medicine and Oncology, Director, Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer InstituteMedStar Georgetown Cancer Institute Washington DC

Publisher

Wiley

Subject

Oncology,Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3